• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

螺旋四氢 β-咔啉(螺旋吲哚酮):一类新型强效、口服有效的疟疾治疗化合物。

Spirotetrahydro beta-carbolines (spiroindolones): a new class of potent and orally efficacious compounds for the treatment of malaria.

机构信息

Novartis Institute for Tropical Diseases, 10 Biopolis Road, no. 05-01 Chromos, Singapore 138670.

出版信息

J Med Chem. 2010 Jul 22;53(14):5155-64. doi: 10.1021/jm100410f.

DOI:10.1021/jm100410f
PMID:20568778
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6996867/
Abstract

The antiplasmodial activity of a series of spirotetrahydro beta-carbolines is described. Racemic spiroazepineindole (1) was identified from a phenotypic screen on wild type Plasmodium falciparum with an in vitro IC(50) of 90 nM. Structure-activity relationships for the optimization of 1 to compound 20a (IC(50) = 0.2 nM) including the identification of the active 1R,3S enantiomer and elimination of metabolic liabilities is presented. Improvement of the pharmacokinetic profile of the series translated to exceptional oral efficacy in the P. berghei infected malaria mouse model where full cure was achieved in four of five mice with three daily doses of 30 mg/kg.

摘要

本文描述了一系列螺环四氢 β-咔啉的抗疟原虫活性。从野生型恶性疟原虫的表型筛选中鉴定出外消旋螺氮杂吲哚(1),其体外 IC50 为 90 nM。通过对 1 进行结构活性关系优化,得到化合物 20a(IC50=0.2 nM),包括确定活性 1R,3S 对映异构体和消除代谢缺陷。该系列药物的药代动力学特性得到改善,在感染疟原虫的疟鼠模型中具有优异的口服疗效,其中 30 mg/kg 剂量,每日三次,连续用药 3 天,5 只鼠中有 4 只完全治愈。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c613/6996867/fab4a5b13367/jm100410f_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c613/6996867/5079250ebb9e/jm100410f_0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c613/6996867/d0e2edfc5da4/jm100410f_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c613/6996867/152ef33a8531/jm100410f_0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c613/6996867/6a2b36806e83/jm100410f_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c613/6996867/d25cad391e19/jm100410f_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c613/6996867/23948c90e168/jm100410f_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c613/6996867/fab4a5b13367/jm100410f_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c613/6996867/5079250ebb9e/jm100410f_0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c613/6996867/d0e2edfc5da4/jm100410f_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c613/6996867/152ef33a8531/jm100410f_0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c613/6996867/6a2b36806e83/jm100410f_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c613/6996867/d25cad391e19/jm100410f_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c613/6996867/23948c90e168/jm100410f_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c613/6996867/fab4a5b13367/jm100410f_0009.jpg

相似文献

1
Spirotetrahydro beta-carbolines (spiroindolones): a new class of potent and orally efficacious compounds for the treatment of malaria.螺旋四氢 β-咔啉(螺旋吲哚酮):一类新型强效、口服有效的疟疾治疗化合物。
J Med Chem. 2010 Jul 22;53(14):5155-64. doi: 10.1021/jm100410f.
2
Spiroindolones, a potent compound class for the treatment of malaria.螺环吲哚酮类,一类用于疟疾治疗的强效化合物。
Science. 2010 Sep 3;329(5996):1175-80. doi: 10.1126/science.1193225.
3
3,5-Diaryl-2-aminopyridines as a novel class of orally active antimalarials demonstrating single dose cure in mice and clinical candidate potential.3,5-二芳基-2-氨基吡啶类化合物作为一类新型的具有口服活性的抗疟药物,在小鼠体内具有单次给药治愈的效果,并具有成为临床候选药物的潜力。
J Med Chem. 2012 Apr 12;55(7):3479-87. doi: 10.1021/jm3001373. Epub 2012 Mar 21.
4
Synthesis and evaluation of beta-carbolinium cations as new antimalarial agents based on pi-delocalized lipophilic cation (DLC) hypothesis.基于π-离域亲脂性阳离子(DLC)假说的新型抗疟药β-咔啉鎓阳离子的合成与评价
Chem Pharm Bull (Tokyo). 2005 Jun;53(6):653-61. doi: 10.1248/cpb.53.653.
5
New synthesis of benzo-delta-carbolines, cryptolepines, and their salts: in vitro cytotoxic, antiplasmodial, and antitrypanosomal activities of delta-carbolines, benzo-delta-carbolines, and cryptolepines.苯并-δ-咔啉、隐色草碱及其盐类的新合成:δ-咔啉、苯并-δ-咔啉和隐色草碱的体外细胞毒性、抗疟和抗锥虫活性
J Med Chem. 2001 Mar 15;44(6):949-60. doi: 10.1021/jm0010419.
6
Identification, design and biological evaluation of bisaryl quinolones targeting Plasmodium falciparum type II NADH:quinone oxidoreductase (PfNDH2).针对恶性疟原虫Ⅱ型烟酰胺腺嘌呤二核苷酸:醌氧化还原酶(PfNDH2)的双芳基喹诺酮类化合物的鉴定、设计和生物评价。
J Med Chem. 2012 Mar 8;55(5):1831-43. doi: 10.1021/jm201179h. Epub 2012 Feb 24.
7
Spiro and dispiro-1,2,4-trioxolanes as antimalarial peroxides: charting a workable structure-activity relationship using simple prototypes.作为抗疟过氧化物的螺环和双螺环-1,2,4-三氧杂环戊烷:使用简单原型构建可行的构效关系。
J Med Chem. 2005 Jul 28;48(15):4953-61. doi: 10.1021/jm049040u.
8
Structure-activity relationship studies of orally active antimalarial 3,5-substituted 2-aminopyridines.具有口服活性的抗疟 3,5-取代 2-氨基吡啶的构效关系研究。
J Med Chem. 2012 Dec 27;55(24):11022-30. doi: 10.1021/jm301476b. Epub 2012 Dec 14.
9
Spiroindolone NITD609 is a novel antimalarial drug that targets the P-type ATPase PfATP4.螺吲哚酮NITD609是一种新型抗疟药物,其作用靶点为P型ATP酶PfATP4。
Future Med Chem. 2016;8(2):227-38. doi: 10.4155/fmc.15.177. Epub 2016 Jan 29.
10
2,4-Diaminothienopyrimidines as orally active antimalarial agents.2,4-二氨基噻吩并嘧啶类化合物作为口服抗疟药物。
J Med Chem. 2014 Feb 13;57(3):1014-22. doi: 10.1021/jm401760c. Epub 2014 Jan 28.

引用本文的文献

1
β-Carboline: a privileged scaffold from nature for potential antimalarial activity.β-咔啉:一种具有潜在抗疟活性的天然优势骨架。
RSC Med Chem. 2025 Aug 27. doi: 10.1039/d5md00299k.
2
Synthesis, crystal structure, Hirshfeld surface, computational and biological studies of spiro-oxindole derivatives as MDM2-p53 inhibitors.作为MDM2-p53抑制剂的螺环氧化吲哚衍生物的合成、晶体结构、 Hirshfeld表面、计算及生物学研究
Mol Divers. 2025 Jun;29(3):2157-2177. doi: 10.1007/s11030-024-10974-x. Epub 2024 Aug 29.
3
A quantum mechanistic investigation into the unusual reactions of nitrilimine and nitrile oxide with 2,3,4,5-tetraphenylcyclopentadienone.

本文引用的文献

1
Spiroindolones, a potent compound class for the treatment of malaria.螺环吲哚酮类,一类用于疟疾治疗的强效化合物。
Science. 2010 Sep 3;329(5996):1175-80. doi: 10.1126/science.1193225.
2
Artemisinin resistance in Plasmodium falciparum malaria.恶性疟原虫疟疾中的青蒿素耐药性。
N Engl J Med. 2009 Jul 30;361(5):455-67. doi: 10.1056/NEJMoa0808859.
3
In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen.计算机模拟活性谱分析揭示了在高通量筛选中发现的抗疟药物的作用机制。
对腈亚胺和氧化腈与2,3,4,5-四苯基环戊二烯酮的异常反应的量子力学研究
J Mol Model. 2024 Jul 25;30(8):282. doi: 10.1007/s00894-024-06074-0.
4
Recent advances, challenges and updates on the development of therapeutics for malaria.疟疾治疗药物研发的最新进展、挑战与动态
EXCLI J. 2024 May 6;23:672-713. doi: 10.17179/excli2023-6856. eCollection 2024.
5
Copper-Catalyzed Enantioselective Synthesis of Spirohydroindoles by Ethoxyformylmethylene Oxindole and Iminoester 1,3-Dipole Cycloaddition: An Examination of Associated Biological Activities.铜催化乙氧甲酰基亚甲基氧化吲哚与亚胺酯1,3-偶极环加成对映选择性合成螺氢吲哚:相关生物活性研究
ACS Omega. 2024 May 28;9(23):24406-24414. doi: 10.1021/acsomega.4c00051. eCollection 2024 Jun 11.
6
Diastereoselective Three-Component 1,3-Dipolar Cycloaddition to Access Functionalized -Tetrahydrocarboline- and Tetrahydroisoquinoline-Fused Spirooxindoles.通过非对映选择性三组分1,3-偶极环加成反应合成官能化的-四氢咔啉和四氢异喹啉稠合的螺环氧化吲哚。
Molecules. 2024 Apr 15;29(8):1790. doi: 10.3390/molecules29081790.
7
Decarboxylative 1,3-dipolar cycloadditions of l-proline.L-脯氨酸的脱羧1,3-偶极环加成反应
RSC Adv. 2024 Mar 13;14(12):8481-8501. doi: 10.1039/d3ra08160e. eCollection 2024 Mar 6.
8
Chemo-/Regio-Selective Synthesis of Novel Functionalized Spiro[pyrrolidine-2,3'-oxindoles] under Microwave Irradiation and Their Anticancer Activity.微波辐射下新型功能化螺[吡咯烷-2,3'-氧吲哚]的 chemo-/Regio-选择性合成及其抗癌活性。
Molecules. 2023 Sep 7;28(18):6503. doi: 10.3390/molecules28186503.
9
Radical Cyclopropanol Ring Opening Initiated Tandem Cyclizations for Efficient Synthesis of Phenanthridines and Oxindoles.基于自由基环丙醇开环引发的串联环化反应高效合成菲啶和氧化吲哚。
Synlett. 2017 May;28(8):913-918. doi: 10.1055/s-0036-1588929. Epub 2017 Jan 10.
10
Lewis acid-catalyzed [4 + 2] cycloaddition of donor-acceptor cyclobutanes with iminooxindoles: access to spiro[piperidine-3,2'-oxindoles].路易斯酸催化供体-受体环丁烷与亚氨基氧化吲哚的[4 + 2]环加成反应:通往螺[哌啶-3,2'-氧化吲哚]的途径
RSC Adv. 2022 Nov 9;12(49):32097-32101. doi: 10.1039/d2ra04730f. eCollection 2022 Nov 3.
Proc Natl Acad Sci U S A. 2008 Jul 1;105(26):9059-64. doi: 10.1073/pnas.0802982105. Epub 2008 Jun 25.
4
Qinghaosu (artemisinin): the price of success.青蒿素:成功的代价
Science. 2008 Apr 18;320(5874):330-4. doi: 10.1126/science.1155165.
5
Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6.恶性疟原虫野外分离株对体外蒿甲醚的抗性及SERCA型PfATPase6的点突变
Lancet. 2005 Dec 3;366(9501):1960-3. doi: 10.1016/S0140-6736(05)67787-2.
6
WHO estimates of the causes of death in children.世界卫生组织对儿童死因的估计。
Lancet. 2005;365(9465):1147-52. doi: 10.1016/S0140-6736(05)71877-8.
7
Studies toward the discovery of the next generation of antidepressants. 3. Dual 5-HT1A and serotonin transporter affinity within a class of N-aryloxyethylindolylalkylamines.新一代抗抑郁药的发现研究。3. 一类N-芳氧基乙基吲哚基烷基胺内的5-HT1A和5-羟色胺转运体双重亲和力。
J Med Chem. 2004 Jul 15;47(15):3823-42. doi: 10.1021/jm0304010.
8
Novel, rapid, and inexpensive cell-based quantification of antimalarial drug efficacy.新型、快速且廉价的基于细胞的抗疟药物疗效定量分析。
Antimicrob Agents Chemother. 2004 May;48(5):1807-10. doi: 10.1128/AAC.48.5.1807-1810.2004.
9
Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening.用于高通量抗疟药物筛选的简单且低成本的荧光技术。
Antimicrob Agents Chemother. 2004 May;48(5):1803-6. doi: 10.1128/AAC.48.5.1803-1806.2004.
10
Novel and potent human and rat beta3-adrenergic receptor agonists containing substituted 3-indolylalkylamines.
Bioorg Med Chem Lett. 2003 Apr 7;13(7):1301-5. doi: 10.1016/s0960-894x(03)00073-8.